3CDE | Transferase | date | Feb 26, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Hcv Ns5b Polymerase With A Novel Pyrida Inhibitor | ||||||||||||||
authors | Q.Zhao, R.E.Showalter, Q.Han, C.R.Kissinger | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Rna-Directed Rna Polymerase Chain: A, B Fragment: Catalytic Domain (Unp Residues 2420-2989) Ec: 2.7.7.48 Engineered: Yes Mutation: Yes |
Organism_scientific: Hepatitis C Virus Strain: Genotype 1b Bk Expression_system: Escherichia Coli Expression_system_strain: Bl21(De3)Star Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet21a | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.10 Å | ||||||||||||
ligand | N3H BindingDB | enzyme | Transferase E.C.2.7.7.48 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)- 5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments., Li LS, Zhou Y, Murphy DE, Stankovic N, Zhao J, Dragovich PS, Bertolini T, Sun Z, Ayida B, Tran CV, Ruebsam F, Webber SE, Shah AM, Tsan M, Showalter RE, Patel R, Lebrun LA, Bartkowski DM, Nolan TG, Norris DA, Kamran R, Brooks J, Sergeeva MV, Kirkovsky L, Zhao Q, Kissinger CR, Bioorg Med Chem Lett. 2008 Jun 1;18(11):3446-55. Epub 2008 Mar 5. PMID:18457949 |
Data retrieval |
View 3CDE in 3D |
Visual 3D analysis of 3CDE |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3CDE |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |